Phase 1 Study of the Selective c-MET Inhibitor, HS-10241, in Patients With Advanced Solid Tumors by Xiaorong Dong, MD, PhD, Xingya Li, MD, Jianhua Chen, MD, Shenglin Ma, MD, Deguang Mu, MD, Jie Hu, MD, PhD, Shun Lu, MD

Get full text

Multiplexed Serum Biomarkers for the Detection of Lung Cancer by Shenglin Ma, MD, Wenzhe Wang, PhD, Bing Xia, MD, Shirong Zhang, MSc, Haining Yuan, MSc, Hong Jiang, MD, Wen Meng, MD, MSc, Xiaoliang Zheng, PhD, Xiaoju Wang, PhD

Get full text